Strategic Wealth Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.27K Buy
306
+11
+4% +$154 ﹤0.01% 1061
2025
Q4
$4.25K Sell
295
-19,608
-99% -$295K ﹤0.01% 1082
2025
Q3
$317K Buy
+19,903
New +$328K 0.02% 277

Other funds holding BTAL

Strategic Wealth Partners's BTAL Position: Q1 2026 in Review

Strategic Wealth Partners increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 3.7% in Q1 2026, buying an estimated $154 and bringing the position to 306 shares worth $4.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Strategic Wealth Partners first reported a position in BTAL in Q3 2025 and has held it in 3 quarters since. The position peaked at $317K in Q3 2025. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.

  • Strategic Wealth Partners held 306 shares of AGF US Market Neutral Anti-Beta Fund worth $4.27K as of Q1 2026.
  • Strategic Wealth Partners bought 11 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $154.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #1061 holding.
  • Strategic Wealth Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2025 and has held it in 3 quarters since.
  • Strategic Wealth Partners's AGF US Market Neutral Anti-Beta Fund position peaked at $317K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.